p.6 抽出テキスト

Figure 18 Algorithm to approach implantable cardioverter defibrillator decision-making in patients with arrhythmogenic right ventricular cardiomyopathy .............................................................................. 3572 Figure 19 Spectrum of restrictive heart diseases .................................... 3573 Figure 20 Anderson–Fabry disease diagnostic algorithm ..................... 3578 Figure 21 Screening for cardiac amyloidosis ............................................. 3580 Figure 22 Diagnosis of cardiac amyloidosis ............................................... 3581

Abbreviations and acronyms

18F-FDG 18F-fluorodeoxyglucose 2D Two-dimensional 3D Three-dimensional 99mTc 99mTechnetium AAD Antiarrhythmic drug ABC Atrial Fibrillation Better Care approach ACE Angiotensin-converting enzyme ACE-I Angiotensin-converting enzyme inhibitor ACM Arrhythmogenic cardiomyopathy AD Autosomal dominant AED Automated external defibrillator AF Atrial fibrillation AFD Anderson–Fabry disease AHA/ACC American Heart Association/American College of Cardiology AL Monoclonal immunoglobulin light chain amyloidosis ALCAPA Anomalous left coronary artery from the pulmonary artery ALT Alanine aminotransferase ALVC Arrhythmogenic left ventricular cardiomyopathy APHRS Asia Pacific Heart Rhythm Society AR Autosomal recessive ARB Angiotensin receptor blocker ARNI Angiotensin receptor neprilysin inhibitor ARVC Arrhythmogenic right ventricular cardiomyopathy ASA Alcohol septal ablation AST Aspartate transaminase ATPase Adenosine triphosphatase ATTR Transthyretin amyloidosis ATTR-CA Transthyretin cardiac amyloidosis ATTR-CM Transthyretin amyloid cardiomyopathy ATTRv Hereditary transthyretin amyloidosis ATTRwt Wild-type OR Acquired transthyretin amyloidosis AV Atrioventricular b.p.m. Beats per minute BAG3 BAG cochaperone-3 BNP Brain natriuretic peptide CAD Coronary artery disease CCB Calcium channel blocker CHA2DS2-VASc Congestive heart failure or left ventricular dysfunction, hypertension, age ≥75 (doubled), diabetes, stroke (doubled)-vascular disease, age 65– 74, sex category (female) (score) CHD Congenital heart disease CK Creatinine kinase CMR Cardiac magnetic resonance COVID-19 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection CPET Cardio-pulmonary exercise testing CPR Cardio-pulmonary resuscitation CRT Cardiac resynchronization therapy CrCl Creatinine clearance CT Computed tomography CTCA Computed tomography coronary angiography DBS Deep brain stimulation DCM Dilated cardiomyopathy DES Desmin DMD Duchenne muscular dystrophy DOAC Direct-acting oral anticoagulant DPD 3,3-diphosphono-1,2-propanodicarboxylic acid DSP Desmoplakin EAST-AFNET Early Treatment of Atrial Fibrillation for Stroke Prevention Trial ECG Electrocardiogram ECHO Echocardiogram ECV Extracellular volume EF Ejection fraction EHRA European Heart Rhythm Association EMB Endomyocardial biopsy EMF Endomyocardial fibrosis EORP EURObservational Research Programme ERN European Reference Network ERT Enzyme replacement therapy FLNC Filamin C FRA Friedreich ataxia FTX Frataxin Gb3 Globotriaosylceramide GDMT Guideline-directed medical therapy GSD Glycogen storage disorder GWAS Genome-wide association study HbA1c Haemoglobin A1C HBP His-Bundle pacing HCM Hypertrophic cardiomyopathy HCMR Hypertrophic Cardiomyopathy Registry HF Heart failure HFmrEF Heart failure with mildly reduced ejection fraction HFpEF Heart failure with preserved ejection fraction HFrEF Heart failure with reduced ejection fraction HMDP Hydroxymethylene diphosphonate HR Hazard ratio HRS Heart Rhythm Society hs-cTnT High-sensitivity cardiac troponin T ICD Implantable cardioverter defibrillator INR International normalized ratio ITFC International Task Force Consensus statement IVF In vitro fertilization LA Left atrium LAHRS Latin American Heart Rhythm Society LBBB Left bundle branch block LGE Late gadolinium enhancement LMNA Lamin A/C LMWH Low-molecular-weight heparin LSD Lysosomal storage disease LV Left ventricular LVAD LV assist device LVEDV Left ventricular end-diastolic volume LVEF Left ventricular ejection fraction LVH Left ventricular hypertrophy Downloaded from academic.oup.com/eurheartj/article/44/37/3503/7246608 by guest on 07 October 2026